These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15117438)

  • 1. Faecal calprotectin: a new marker for Crohn's disease?
    Wassell J; Dolwani S; Metzner M; Losty H; Hawthorne A
    Ann Clin Biochem; 2004 May; 41(Pt 3):230-2. PubMed ID: 15117438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
    Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H
    Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
    Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
    Schröder O; Naumann M; Shastri Y; Povse N; Stein J
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1035-42. PubMed ID: 17877510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
    Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal calprotectin: the case for a novel non-invasive way of assessing intestinal inflammation.
    Gearry R; Barclay M; Florkowski C; George P; Walmsley T
    N Z Med J; 2005 May; 118(1214):U1444. PubMed ID: 15886739
    [No Abstract]   [Full Text] [Related]  

  • 8. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].
    van den Bergh FA; Kolkman JJ; Russel MG; Vlaskamp RT; Vermes I
    Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2360-5. PubMed ID: 14677476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal calprotectin in the assessment of Crohn's disease activity.
    Gaya DR; Lyon TD; Duncan A; Neilly JB; Han S; Howell J; Liddell C; Stanley AJ; Morris AJ; Mackenzie JF
    QJM; 2005 Jun; 98(6):435-41. PubMed ID: 15879440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease.
    Reinders CA; Jonkers D; Janson EA; Stockbrügger RW; Stobberingh EE; Hellström PM; Lundberg JO
    Scand J Gastroenterol; 2007 Oct; 42(10):1151-7. PubMed ID: 17852876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.
    Scarpa M; D'Incà R; Basso D; Ruffolo C; Polese L; Bertin E; Luise A; Frego M; Plebani M; Sturniolo GC; D'Amico DF; Angriman I
    Dis Colon Rectum; 2007 Jun; 50(6):861-9. PubMed ID: 17473939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
    Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
    Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease.
    Costa F; Mumolo MG; Ceccarelli L; Bellini M; Romano MR; Sterpi C; Ricchiuti A; Marchi S; Bottai M
    Gut; 2005 Mar; 54(3):364-8. PubMed ID: 15710984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of faecal calprotectin as non-invasive marker of intestinal inflammation.
    Costa F; Mumolo MG; Bellini M; Romano MR; Ceccarelli L; Arpe P; Sterpi C; Marchi S; Maltinti G
    Dig Liver Dis; 2003 Sep; 35(9):642-7. PubMed ID: 14563186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases].
    Mekkel G; Barta Z; Ress Z; Gyimesi E; Sipka S; Zeher M
    Orv Hetil; 2005 Apr; 146(17):797-802. PubMed ID: 17918636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease.
    Røseth AG; Aadland E; Grzyb K
    Scand J Gastroenterol; 2004 Oct; 39(10):1017-20. PubMed ID: 15513345
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice.
    Berni Canani R; Rapacciuolo L; Romano MT; Tanturri de Horatio L; Terrin G; Manguso F; Cirillo P; Paparo F; Troncone R
    Dig Liver Dis; 2004 Jul; 36(7):467-70. PubMed ID: 15285526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology.
    Dolwani S; Metzner M; Wassell JJ; Yong A; Hawthorne AB
    Aliment Pharmacol Ther; 2004 Sep; 20(6):615-21. PubMed ID: 15352909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
    Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
    Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL; Raivio T; Lindahl H; Savilahti E
    Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.